What dose of AMT do you take daily? Is it a single dose in the morning, or is re-dosing involved? What issues do you believe it resolves? Remember that it is not simply a tryptamine, it also has phenylethylamine characteristics, and given the toxicity of it's close analogue AET it is likely to have similar neurotoxicity. Especially considering their mechanisms of action are virtually identical, it even has the potential to cause agranulocytosis just like AET given it's known effects in reducing the granulocyte population in humans.
That's interesting what you mention about the Memantine being dopaminergic, it is something I have considered trying, but currently the potential negative effects on cognition put me off.
I take 7,5mg AMT in the morning, it never wears off for me, atleast it works untill i go to sleep even if i wake up 6 o clock for work and go sleep 3 o clock at night, i never redose during the day and i make sure to allways take a break of a few days once and awhile.
Yes i'm absolutely convinced it has the same neurotoxiticy as AET however i think this would be minimal in therapeutic doses, since monoamine release would be low (atleast far lower then recreational doses) and hyperthermia (essential for MDMA induced neurotoxiticy) is minimal.
Still keeping potential toxiticy in mind is allways a good idea for me the benefits definatly outweigh the risk. (or what i assume are the risk, getting all research papers will give us more answers).
As far as agranulocytosis you can be correct that its an issue, however indopan seemed to have been in clinical use for 20 years, and a moderator on bluelight (i know this isnt really evidence but its someone i would trust, even tough he uses recreational drugs, he's aware of the potential risks, and also was one of the main guys
against the toxic mephedrone.)
Has checked out the russion toxicology database to check for any issues and said nothing was documented.
He also looked into the papers im trying to get atm, here's a list of the most interesting one's:
Title: [APROPOS OF THE USE OF INDOPAN IN CLINICAL PSYCHIATRY.]
Author: LEVIT, V G
Add.Author / Editor: MOROZOVA, T N
POPOVA, A N
Citation: Zh Nevropatol Psikhiatr Im S S Korsakova
Volume: 64, Date: 1964 , Pages: 768-70
http://www.labmeetin...ical-psychiatryTitle: [Pharmacological properties of indopane (alpha-methyltryptamine HCl).]
Author: MASHKOVSKII, M D
Add.Author / Editor: TRUBITSYNA, T K
http://www.labmeetin...yptamine-hcl%29Title: [On the mechanism of action of indopan]
Author: Popova, E N
Citation: Zh Nevropatol Psikhiatr Im S S Korsakova
Volume: 67, Issue: 1, Date: 1967 , Pages: 125-31
http://www.labmeetin...tion-of-indopanTitle: [Effect of indopan on cerebral circulation]
Author: Mashkovskiĭ, M D
Add.Author / Editor: Lanskiĭ, V P
Citation: Farmakol Toksikol
Volume: 31, Issue: 5, Pages: 587-90
http://www.labmeetin...ral-circulationTitle: [EFFECT OF INDOPAN ON THE BIO-ELECTRIC ACTIVITY OF THE BRAIN.]
Author: ROSHCHINA, L F
Add.Author / Editor: MASHKOVSKII, M D
Citation: Zh Nevropatol Psikhiatr Im S S Korsakova
Volume: 63, Date: 1963 , Pages: 1679-87
http://www.labmeetin...ty-of-the-brainTitle: [Morphophysiologic studies of the effect of indopan on the process of higher nervous activity]
Author: Krivitskaia, G N
Add.Author / Editor: Mering, T A
Citation: Zh Vyssh Nerv Deiat Im I P Pavlova
Volume: 16, Issue: 4, Pages: 648-54
http://www.labmeetin...ervous-activityTitle: [Group toxicity of indopan and its reaction to various neurotropic drugs]
Author: Trubitsyna, T K
Add.Author / Editor: Mashkovskiĭ, M D
Citation: Farmakol Toksikol
Volume: 28, Issue: 1, Pages: 23-7
http://www.labmeetin...urotropic-drugsTitle: Activation of brain 5-HT neurons by two alpha-methylated tryptamine derivatives.
Author: Arai, Y
Add.Author / Editor: Tadano, T
Yonezawa, A
Fujita, T
Kinemuchi, H
Kisara, K
http://www.labmeetin...ine-derivativesPubget doesnt hold the PDF's on any of them, however ppl have suggested me to go to university's and ask there.
I'm also trying to get this paper:
Agranulocytosis following Monase therapy.
BUTIN JW.
J Kans Med Soc. 1962 Aug;63:338-40. No abstract available.
PMID: 13875179 [PubMed - indexed for MEDLINE]
Related citations
To see how big the risk of agranulocytosis was with AET.
Regarding memantine, well id say its definatly worth a try, you can allways see for yourself wheter its effect on cognition will be an issue,
subjectively i notice more clarity and dont notice any cognitive impairment after the initial adaptation phase.
Edited by medievil, 24 October 2010 - 06:23 PM.